Author: Sharon Malone

Dr. Sharon Malone is a nationally recognized physician and expert in women’s health and menopause care.

This FDA Decision Could Transform Menopause Care

and

On Monday, Nov. 10, the U.S. Department of Health and Human Services announced that the Food and Drug Administration would eliminate the “boxed labeling” requirement for estrogen products.

The “black box warning,” as it’s commonly called, is part of the fallout from a press conference that occurred more than 20 years ago, announcing the findings of the Women’s Health Initiative (WHI). It’s also been the subject of a half-century-long push and pull with the federal government.

Make no mistake, this has been a longstanding demand—it’s neither new nor MAHA-driven. Doctors and scientists have made the case for its removal since the start to no avail, arguing the data from the WHI—the largest, most expensive, and only randomized placebo-controlled study of post-menopausal women—never supported putting it there in the first place.

The FDA’s reversal of the labeling requirement is a major win for evidence-based medicine. Now it’s up to us to responsibly inform women of their choices.

America’s Healthcare Crisis Is Coming for All Women

and

Less access to healthcare—either by cutting Medicaid benefits or discouraging doctors from practicing in restrictive states—will affect antiabortion and pro-abortion women equally.

This is about far more than abortion. There will be more maternal deaths. There will be more deaths from cervical and breast cancer. More women will die from complications of cardiovascular disease and diabetes. There will be more suffering from infertility, endometriosis and fibroids.

Does anyone in power care? We certainly do. And we better make sure our voices are heard. All of our lives depend on it.

Kamala Harris Is Older, Wiser … and Cooler

and

Kamala Harris has rapidly assumed the mantel of cool, youthful candidate. Among Gen Z, she is “brat,” with Charli XCX, Olivia Rodrigo and Beyoncé lining up fast for the cause. Among the older crowd, longstanding debate over whether the vice president qualifies as a Baby Boomer—born in 1964, she is just on the cusp—rages on. It is apparently a hill Gen X is prepared to die on, citing her penchant for Chuck Taylors as proof.

Either way, at nearly 60 years old, Harris has achieved what might have seemed impossible before this moment: She has changed the perception of what it looks and sounds like to be a vibrant and capable “older” woman. We see a woman who radiates from the certainty of age and of knowing herself. Quite frankly, it is a gorgeous sight.

Menopause Went Prime Time at the Super Bowl. Now the Federal Government Must Step Up

and

Menopause has been sorely neglected by the mainstream medical establishment, by lawmakers, by employers and by just about everyone. As a result, millions of women are left to navigate its most debilitating symptoms with little support.

Menopause is clearly having a prime-time moment—and we think that’s worth cheering. We challenge the National Institutes for Health to design and launch a modern initiative to assert the long-term benefits of hormone therapy and accurately assess its risks.